... I've got a $5 bet with Scott that it, I can't make it in 25 minutes, so it's big money. So somebody, don't ask questions once we get to 25 minutes, we can end this. Okay, SOBRs afe, we're on the Nasdaq. We went public about three years ago in May, and we've got alcohol monitoring and detection technology with the objective replacing breathalyzers. So a little housecleaning, forward-looking statements. So revenue through second quarter is nascent, but what we think is important is that the company is gaining traction, going from early adoption customers in the space that we're in, and I'll talk about that in a little bit, to market expansion. Headquartered in Greenwood Village, got a market cap, I don't know, I didn't look at the stock today.
We've got about a year's worth of cash right now, and we're in pretty good position to grow the business. Our objective at SOBRs afe is to create the new standard for alcohol detection. Breathalyzer's been in place since 1951. We'll further explain as we go through this process, but our goal is to change and create a new standard for detection using our technology and our algorithms. Again, here's the new standard. Hardware and software, SaaS combination. So with the hardware that looks like a mouse, that's the SOBRc heck. It's stationary. That device goes in locations where people are checking in or checking out.
The band, I'll talk a little bit more about this in the presentation, connected to the phone, tethered to the phone, and both the band and the SOBRc heck operate on the same dashboard, with all software combined for easy management for the clinicians and for the individuals that are wearing the device. Our market, so if you followed our company prior, a couple of years back, we started in the fleet and warehousing space. Trying to create a standard in that space was pretty difficult, and cases of fleet in warehousing, when accidents occur, then they do alcohol testing. So trying to get that box and the technology in front of the problem didn't really work out for us, and we didn't have the time or the money to make that market.
We shifted to behavioral health, where there are 46,000 facilities in the U.S., and in those facilities, we can use the SOBRc heck stationary version when people check in and check out, and then when people get out of the facility, then we use our band. We've got the judicial, family law, and personal consumer market, but the focus of the sales force for the company is behavioral health, B2B, and then we've got a consumer plan that we manage from a digital perspective, and there's a little bit of bleed from family law and judicial. Same use case. Example, with family law, individual gets divorced, and the spouse is drinking, and they have to watch the kids over a weekend. They wear the band, so to make sure the kids are safe.
There's a little bit of bleed over, and then judicial, what we see is pre-court cases where somebody has a DUI. They have to show that they've been abstaining from alcohol. They wear our band, they go in, we have a series of reports, and they show the judge that they've been alcohol-free, and hopefully, that improves or reduces their sentence, their timing. Addressable market. We've got 28.9 million individuals that are diagnosed with Alcohol Use Disorder. Out of that group, there's probably 2.5-2.8 million that are looking for a solution and involved in behavioral health, and the balance of those individuals we manage through the consumer digital marketing program. We're chasing those down and trying to develop and fine-tune the submarkets so we can turn these pings into sales.
Again, focus, behavioral health and consumer markets. Our two applications, hardware and software-based. On the far left, the SOBRc heck. I do have one with me. I could probably grab out of my briefcase and pass it around. Stationary screening device used for check-in, check-out. Chris has the wearable with him somewhere. He can maybe pass that around. It's a wearable band, continuous monitoring, as I said earlier, paired to your phone, to the cloud, and everything shows up on this dashboard that you see to the right. So in a facility where they're managing multiple patients, we'll have these devices, and they'll be able to look at and click on the individual and find out if that individual's okay. If there's a flag, they can locate that individual and try to get that individual help sooner rather than later.
Our pricing, $199 for the band, $15.99-$34.99 a month, depending on the program that you choose. The SOBRc heck device, $799 for the device. $250 a month is the minimum, and it's $10 per user, on a SaaS model. So, one-year contract for the Check, three, six, and twelve-month contract for the SOBRsure band. Important to note that on the right there, SOBRlink, remote breath, they've been in the market for over 10 years. We are going after SOBRlink to take market share from them, and if you look at the $15.99-$34.99, they're at $135-$265. So we are seeing some early traction and adoption in competing with SOBRlink.
If you look at this matrix, there's a lot of tremendous features that we have that aren't available with breathalyzers and some of the remote breath products. Again, you see humane, real-time process, connected, non-invasive. You're not blowing into something, so it's extremely hygienic, and what we found in the behavioral health space is the individuals that have had issues with alcohol, every time they blow into that breathalyzer, it brings back that point in time when they started their journey or their journey ended with alcohol, and they were off to sobriety. Just to give you a little bit of background, in Q4 of 2023, we pivoted to behavioral health, as I mentioned earlier, because there was a function there where testing was being done using the breathalyzer.
And then we also, at that point in time, we designed and launched the Gen 2 version. And then, as you can see, going forward, we got a comprehensive branding strategy on the digital side for consumer and behavioral health. We have a direct sales force that sells into behavioral health. We have a sales force of four and a lead, and then initial traction, again, decent numbers, but our validations show you that we are increasing, we are moving the business forward, and we are signing customers and going from early adopters to market traction. Again, you folks looking at these numbers, they're not big numbers, but they're big to us, with 55 devices installed right now in facilities, and I think somewhere around 500 users and 300 SOBRsure bands that have been ordered.
So we're making significant progress, and it's a step at a time. We keep our heads down and keep our plan in place and execute on that plan. Additional promising market opportunities, which Scott always asks me, "When can we announce any of these? Are any of these announceable?" Well, not really, not yet. But just to give you an idea, internationally, we're providing a product in Australia and New Zealand right now, and that product is going again in behavioral health space, and we launched it at the beginning of the year. We are testing right now at the New Delhi airport in India, and they've got a significant alcohol issue there. If that test comes out and it's proved that our devices would be able to replace the breathalyzer, then we would start sales opportunities in India.
We're testing in Italy with Vodafone. They're concerned about their drivers being safe and not using alcohol during the day as they make their runs to support their customers, and that test will be done probably by the end of September, and then we're doing something similar in the United Kingdom, so we've got other countries that are reaching out to us that have more strict alcohol standards, and we're in the process. We call these long poles. We're in the process of managing these long poles to try to get them across the line to give us some global opportunities, and then licensing the technology, I mean, we've talked. We had six or seven meetings today, and everybody comes up, "You should license.
You should partner." Well, some of these things that we're working on are exactly that, but the objective is once we further establish ourselves in the market we're in behavioral health and consumer, then there's an opportunity for us to really leverage the technology and look at doing some licensing agreements. And I mean, if you think about, for example, Fitbit, if, if they had an alcohol sensor in their device or other similar bands, once we have credibility and we've proven ourselves in the market, we would have those opportunities to have those conversations. So licensing is definitely in our future. Global expansion is really based on each of these countries that I'd mentioned, and if they're successful, then Chris and I need to figure out what the strategy is.
But the important thing to note is that the sales force is focused around behavioral health, and any of these other deals are company management, 'cause we wanna keep the sales guys focused on the markets that we're in. Financial and operational highlights. You can see revenue again moving in the right direction, the recurring revenue moving in the right direction. We've got about a year's worth of cash right now in the bank, and we think we can execute our next six- to eight-month strategy with that cash, so we're comfortable there. And we've cleaned up our balance sheet. We have no debt. And then again, some highlights here. Chris Peterson just joined the board a few months back. She's a significant add to the board. She's around the governance space.
She, she's got many years of public company and board experience. Benjamin Sanchez is a scientific board advisor. He's helping us. We're actually working with Texas Instruments right now on some potential opportunities launched by Benjamin. And then, one of the bigger things we've done this year is we've relaunched or launched a new e-commerce platform with Chris, if you can just say a few words about why that's important. You'd do better than I do.
Right. So we brought an e-commerce platform to the market, where our B2B consumers can then self-manage their particular purchases, their subscriptions, and then manage exactly how much they're spending on their product. That also augments to our products that we provide on the software side, which is a dashboard, a console, and a portal for B2B consumers that also extends-
He's not a lead singer.
Yeah, I'm not. I don't do this often with a microphone. But, so that particular e-commerce platform serves both B2B, B2C, and delivers our SaaS products to each one of the respective customers across the board. That is something that none of our competitors do in the space. We just now have the foundation. Our next set of objectives is to expand on that.
And then we did receive our European patent about six weeks ago or so for the SOBRcheck device. So that gives us the ability to, you know, to create additional licensing opportunities throughout Europe, and we're, like I said, we're working in Italy, and I forgot to mention also the Netherlands. So there's some opportunity for us to expand there, but we wouldn't directly do that. We'd partner with a distribution partner or channel to get that done. Key investment highlights. So, we've got proprietary technology. It's been developed. It's in patent or patent pending. We've got a very large addressable market, but we're specifically focused on behavioral health in certain consumer markets.
We've got the capital, so we're poised to execute our plan, and right now we're just moving the business forward, and I, like I said earlier, we're in market adoption phase now. So we're kind of through early adopters. Every month our sales are continuing to improve, so we're moving the needle in the right direction, and we're super excited. Again, great to talk to all of you and have the exposure for SOBRs afe. Did I win the $5?
No, I got a question.
Sure.
Can you drill down on, actually, the technology, how it compares to the breathalyzer and why it's superior to the breathalyzer and its accuracy?
Yeah, sure. So we use transdermal skin touch technology, and we have modified with the manufacturer the technology, so it reads a little bit earlier, and it reads a little bit longer. But compared to the breathalyzer, we are somewhat equal to the breathalyzer in general, but where we're better is early detection and longer detection. So we've done a number of tests. Matter of fact, we did one of the big companies in the space took one of our sensors, or several sensors, did some testing. 1.8 million tests they did, and our sensor came out better in performance than the leading sensor that's currently in that ankle monitor space. We also have third-party validation, and we've sent out press releases on that. So this is not coming from us in our garage.
This is coming from third party, so we're earlier, we're longer, and the technology is similar, but it's transdermal.
Amazing.
Good. Any more questions?
Can you maybe walk through some of the licensing opportunities of what you're seeing in India and kind of the use case, and where do you think that could go?
Sure. We have a partner in India that is working with these Indian companies because of the language barrier, because of a lot of different things from a business perspective. Chris and I selected a partner, and they're working with these companies in India. We have right now an in-vehicle device using our sensor. If you put your finger on the sensor and you have alcohol in your system, it's disabling the start of the vehicle. We begin some testing, probably in the next month or so, with the ministry in India because they're concerned about drivers and issues with alcohol with their vehicles, the vehicles owned by the country and managed by the country. We've also had reproduction of the band and reproduction of our stationary device because our pricing is too...
It's unaffordable for India. So we've got those three irons in the fire right now, and we'll probably get some update on that, I'd say, in the next month or so. But if that triggers, then we would do a licensing agreement with this company. They would manufacture in India. They would sell to the customers in India, and then we would have that agreement, which we'd get a percentage of the monthly software piece and a percentage of the equipment. So that's in motion. It's been in motion for about a year and a half, but it's kinda coming to a close, either left turn or right turn. Well, thank you very much, everybody. Have a great evening and the rest of the day. Appreciate it.